https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-702008-02-01 00:00:002019-02-15 09:19:20Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-562008-02-01 00:00:002019-02-15 09:17:41Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-782008-02-01 00:00:002019-02-15 09:17:40Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-212008-02-01 00:00:002019-02-15 08:59:48Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-442008-02-01 00:00:002019-02-15 08:59:46Dendritic cell-based immunotherapy for malignant glioma
